Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where treatment method selections remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/investors-wary-of-shiba-inu-and-cardanos-downtrend-move-to-this-new-coin-with-20x-potential/